Regeneron Pharmaceuticals

REGN · NASDAQ · USD

735,20 $Variación respecto al cierre anterior: +0,05 %Variación absoluta: +0,39 $

Cierre · 2 de octubre de 2026

En resumen

Crecimiento de los ingresos
+0,99 %
2025 frente a 2024
Crecimiento del beneficio neto
+2,09 %
2025 frente a 2024
Margen neto
31,4 %
2024: 31,1 %

Datos financieros

Importes en millones de USD; valores por acción en USD; acciones en millones.

Balance · Trimestral
PartidaT2 2026T1 2026T4 2025T3 2025T2 2025T1 2025T4 2024T3 2024T2 2024T1 2024T4 2023T3 2023
Activo total41.73140.86940.55940.16938.21937.54537.75937.44236.08734.37033.08032.163
Activo corriente18.44618.20918.02217.98116.86017.57218.66119.33419.08218.87219.47918.635
Efectivo y equivalentes2.4562.9633.1182.5061.9963.0902.4882.0121.9212.6022.7302.152
Inversiones a corto plazo5.5395.7915.4875.9375.4745.2596.5247.7857.8887.9188.1157.761
Cuentas por cobrar6.5655.7315.7415.6875.6105.5616.2126.1075.7175.2225.6675.585
Existencias3.0843.1043.2013.2543.2063.1923.0873.0182.8742.7152.5812.562
Inmovilizado material neto5.4595.2665.3665.0024.8414.6944.8174.4394.3064.2264.2244.006
Otros activos intangibles1.3101.2871.2571.3811.3521.1671.1491.1201.1021.0591.0391.017
Inversiones a largo plazo10.63010.52810.59510.70110.4679.6659.0608.6517.9197.0535.4715.839
Pasivo corriente5.5315.1084.3684.4253.6673.5673.9443.6613.5093.5813.4233.599
Proveedores1.1591.027939904724706790497562671607537
Deuda a largo plazo1.9871.9861.9861.9861.9851.9851.9841.9841.9841.9831.9831.983
Deuda total2.7072.7062.7062.7062.705———————
Pasivo total10.0199.4459.3029.2128.2808.1588.4068.1167.8817.3797.1077.259
Patrimonio neto (incl. minoritarios)31.71131.42431.25730.95829.93929.38829.35429.32628.20626.99125.97324.904
Reservas37.62136.42435.79735.04633.68032.38431.67330.75529.41527.98227.26026.101